目的 :观察网状支架治疗良性前列腺增生 (BPH)的临床效果。方法 :对 36例BPH患者放置网状支架进行治疗 ,并分别于治疗后 6、12、2 4、4 8～ 6 0个月进行随访。结果 :全部患者术后均恢复排尿 ,早期有膀胱刺激征和血尿。获 2年以上随访的 17例患者 ,国际前列腺症状评分 (IPSS)从术前 2 8.6± 6 .2分减小至 6 .3± 3.9分 (P<0 .0 0 1) ,平均尿流率 (AFR)从术前 6 .8± 3.2ml s增加至 13.6± 6 .2ml s(P <0 .0 0 1) ,剩余尿量 (RUV)从术前15 6± 2 3.4ml减小至 4 2 .6± 30 .2ml(P <0 .0 0 1)。随访 4 8～ 6 0个月的 8例患者发生尿潴留 ,其中 3例作开放手术切除前列腺 ,1例拔除支架管后行前列腺电切术 ,另 4例行膀胱穿刺造瘘。结论 :网状支架是高危BPH患者的一种安全有效的近期治疗方法 ;放置支架管时间过长 ,可再次出现尿潴留 ,应根据患者情况作出适当处理 Objective: To observe the clinical effect of mesh stent in the treatment of benign prostatic hyperplasia (BPH). Methods: Thirty-six patients with BPH were treated with reticular stents and were followed up 6, 12, 22, 44, 80-60 months after treatment. Results: All patients recovered urination postoperatively, early bladder irritation and hematuria. Among the 17 patients who were followed up for more than 2 years, the International Prostate Symptom Score (IPSS) decreased from 2 8.6 ± 6.2 to 6.3 ± 3.9 (P 0 .01), and the mean urinary flow rate (AFR) increased from 6.8 ± 3.2ml s to 13.6 ± 6.2ml s (P0.001) preoperatively and the residual urine volume (RUV) decreased from 15 6 ± 2 3.4ml preoperatively to 4 2 .6 ± 30 .2 ml (P <0 .0 0 1). Urine retention occurred in 8 patients who were followed up for 48 to 60 months. Three of them underwent open surgery to remove the prostate, one underwent resection of the prostate and prostatectomy. The other 4 underwent bladder puncture and fistula. Conclusion: Reticular stents are a safe and effective near-term treatment for patients with high-risk BPH. Urinary retention may occur again after stent placement for a long time, and should be appropriately treated according to the patient’s condition